Asia PEVC, Author at AsiaPEVC.com

Euro Manganese Announces Results of Annual General and Special Meeting

Euro Manganese Inc. (TSXV: EMN) (ASX: EMN) (FSE: E060) (the “Company” or “EMN”) is pleased to announce that shareholders have voted in favour of all matters of business brought before them at the Company’s Annual General & Special Meeting of Shareholders (the “Meeting”) held on May 15, 2025. Detailed results of the voting from the Meeting are set out below.

In addition, the Company announces an upcoming change to its Chief Financial Officer effective at the end of the month. See below for details.

In respect of Resolution 1, election of the Company’s directors, all five management nominees standing for election were elected as set out below based on a vote conducted by ballot:

Nominee	Total Votes Cast	Votes For	% For	Votes Withheld (Abstained)	% Withheld (Abstained)
John Webster	35,504,229	30,473,634	85.83	5,030,595	14.17
David B. Dreisinger	35,504,229	30,289,601	85.31	5,214,628	14.69
Thomas M. Stepien	35,504,229	30,298,601	85.34	5,205,628	14.66
Ludivine Wouters	35,504,229	33,904,004	95.49	1,600,225	4.51
Rick Anthon	35,618,229	33,735,888	94.72	1,882,341	5.28

The following matters of business at the Meeting, which were also carried out and decided by ballot, were approved:

	Total Votes	Votes For	% For	Votes Against	% Against	Votes Withheld /Abstained
Resolution 2 – Appointment of Pricewaterhouse- Coopers LLP as Auditors of the Company	35,645,599	31,760,224	89.10	N/A	N/A	3,885,375
Resolution 3 – Re-approval of the Company’s Stock Option Plan⁽¹⁾	35,504,229	32,389,657	91.23	2,963,702	8.35	150,870

⁽¹⁾ In accordance with the rules of the Australian Securities Exchange (the “ASX“), shareholders of the Company also approved the Company’s stock option plan by a majority of the votes cast, with the 455,661 votes cast by directors of the Company excluded and reclassified as withheld/abstain. Based on this exclusion and reclassification, the total number of votes cast in respect of this resolution was 35,504,229, of which 31,933,996 votes were cast for the resolution, representing 89.94% of the total votes cast, 2,963,702 votes were cast against the resolution, representing 8.35% of the total votes cast, and 606,531 votes were withheld/abstain, representing 1.71% of the total votes cast.

Additionally, for purposes of the ASX, shareholders of the Company also approved each of the following resolutions:

a) for the purpose of Listing Rule 7.1 of the ASX, the issuance of 21,400,000 Units comprising of 21,400,000 Shares and 21,400,000 Warrants to the European Bank for Reconstruction and Development (the “EBRD“) and the issuance of up to 18,063,331 Units comprising of 18,063,331 Shares and 18,063,331 Warrants, and 14,650,278 Units comprising of 14,650,278 CHESS Depositary Interests (“CDIs“) each representing one Share and 14,650,278 Warrants to sophisticated and professional investors, respectively, (the “Offering“);

b) for the purpose of Listing Rules 10.11.1 and 10.11.4 of the ASX, the issuance to the following individuals of Units under the Offering on terms and conditions identical to all other subscribers under the Offering:

(i) 55,555 Units, comprising of 55,555 Shares and 55,555 Warrants, to JJW Investments Ltd., a company controlled by Mr. John Webster;

(ii) 41,666 Units, comprising of 41,666 Shares and 41,666 Warrants, to Dr. David B. Dreisinger.

(iii) 55,555 Units, comprising of 55,555 Shares and 55,555 Warrants, to Mr. Thomas M. Stepien.

(iv) 55,555 Units, comprising of 55,555 Shares and 55,555 Warrants, to Ms. Ludivine Wouters; and

(v) 256,410 Units, comprising of 256,410 CDIs and 256,410 Warrants, to Mr. Rick Anthon;

c) for the purpose of Listing Rule 7.1 of the ASX, the issuance of 4,904,478 broker warrants (the “Broker Warrants“) to Canaccord Genuity (Australia) Limited (“Canaccord“) and Foster Stockbroking Pty Ltd. (“FSB“), in connection with their remuneration for acting as co-lead managers of the Offering;

d) for the purpose of Listing Rule 7.1 of the ASX, the issuance of 7,692,307 CDIs and 7,692,307 Warrants to Eligible Shareholders under the Share Purchase Plan (“SPP“) on the terms and conditions described in the prospectus issued to Eligible Shareholders; and

e) for the purpose of Listing Rule 7.1 of the ASX, the issuance of 22,263,733 Orion Warrants to OMRF (BK) LLC (“Orion“) as compensation for certain amendments to the Convertible Loan and Royalty Agreement.

In accordance with Listing Rule 3.13.2(d) of the ASX, detailed results of the voting from the Meeting, on the resolutions outlined above, all of which were carried out and decided by ballot, are set out below.

	Total Votes	Votes For	% For	Votes Against	% Against	Votes Withheld /Abstained
Resolution 4(a) – Issuance of 54,113,609 Units comprising 39,463,331 Shares and 14,650,278 CDIs and 54,113,609 Warrants to Non-Related Party Investors and the EBRD	35,504,229	27,456,337	77.33%	1,228,296	3.46%	6,819,596
Resolution 4(b)(i) – Issuance of 55,555 Units, comprising of 55,555 Shares and 55,555 Warrants, to JJW Investments Ltd.	35,504,229	33,171,670	93.43	1,235,052	3.48	1,097,507
Resolution 4(b)(ii) – Issuance of 41,666 Units, comprising of 41,666 Shares and 41,666 Warrants, to Dr. David B. Dreisinger	35,504,229	33,187,967	93.48	1,235,052	3.48	1,081,210
Resolution 4(b)(iii) – Issuance of 55,555 Units, comprising of 55,555 Shares and 55,555 Warrants, to Mr. Thomas M. Stepien	35,504,229	33,407,649	94.09	1,235,052	3.48%	861,528
Resolution 4(b)(iv) – Issuance of 55,555 Units, comprising of 55,555 Shares and 55,555 Warrants, to Ms. Ludivine Wouters	35,504,229	33,196,678	93.50	1,234,188	3.48	1,073,363
Resolution 4(b)(v) – Issuance of 256,410 Units, comprising of 256,410 CDIs and 256,410 Warrants, to Mr. Rick Anthon	35,504,229	33,469,602	94.27%	1,234,188	3.48	800,439
Resolution 4(c) – the issuance of 4,904,478 Broker Warrants to Canaccord and FSB	35,504,229	30,898,394	87.03%	1,163,498	3.28%	3,442,337
Resolution 4(d) – the issuance of 7,692,307 CDIs and 7,692,307 Warrants to Eligible Shareholders under the SPP	35,504,229	33,324,730	93.86%	906,086	2.55%	1,273,413
Resolution 5 – the issuance of 22,263,733 Orion Warrants to Orion	35,504,229	33,362,546	93.97%	1,184,924	3.34%	956,759

The Company disregarded the following votes, from the applicable resolutions, as required by Listing Rule 14.11 of the ASX:

a) votes cast by the EBRD or any person (or any associates of such person) who is expected to participate in, or who will obtain a material benefit as a result of, the proposed issuance of Shares or CDIs under the Offering (except a benefit solely by reason of being a holder of ordinary shares in the Company) from Resolution 4(a);

b) votes cast by any person (or any associates of such person) who is expected to participate in, or who will obtain a material benefit as a result of, the proposed issuance of securities under the Offering (except a benefit solely by reason of being a holder of ordinary shares in the Company) from Resolutions 4(b)(i), 4(b)(ii), 4(b)(iii), 4(b)(iv);4(b)(v) and 4(c);

c) votes cast by Canaccord and FSB (or any associates of Canaccord and FSB) who will be receiving Broker Warrants (except a benefit solely by reason of being a holder of ordinary shares in the Company) from Resolution 4(c);

d) votes cast by any person (or any associates of such person) who is expected to participate in, or who will obtain a material benefit as a result of, the proposed issuance of securities under the SPP (except a benefit solely by reason of being a holder of ordinary shares in the Company) from Resolution 4(d); and

e) votes cast by Orion (or any associates of Orion) or any person (or any associates of such person) who will be receiving Orion Warrants (except a benefit solely by reason of being a holder of ordinary shares in the Company) from Resolution 5.

Accordingly, the following voting exclusions applied to each of the resolutions below as required by the rules of the ASX:

Resolution 4(a): Total votes for Resolution 4(a) exclude 6,527,532 votes cast by parties participating in the Offering, including the EBRD and the directors. The excluded votes are reclassified to votes withheld/abstain, resulting in no change to the total Shares being voted in connection with Resolution 4(a).

Resolution 4(b)(i): Total votes for Resolution 4(b)(i) exclude 235,979 votes cast by John Webster (and entities controlled by him, including JJW Investments Ltd.) who subscribed for Units in the Offering. The excluded votes are reclassified to votes withheld/abstain, resulting in no change to the total Shares being voted in connection with Resolution 4(b)(i).
Resolution 4(b)(ii): Total votes for Resolution 4(b)(ii) exclude 219,682 votes cast by David Dreisinger (and entities controlled by him) who subscribed for Units in the Offering. The excluded votes are reclassified to votes withheld/abstain, resulting in no change to the total Shares being voted in connection with Resolution 4(b)(ii).
Resolution 4(b)(iii): Total votes for Resolution 4(b)(iii) exclude nil votes cast by Thomas Stepien (and entities controlled by him) who subscribed for Units in the Offering.
Resolution 4(b)(iv): Total votes for Resolution 4(b)(iv) exclude nil votes cast by Ludivine Wouters (and entities controlled by her) who subscribed for Units in the Offering.
Resolution 4(b)(v): Total votes for Resolution 4(b)(v) exclude nil votes cast by Rick Anthon (and entities controlled by him) who subscribed for Units in the Offering.
Resolution 4(c): Total votes for Resolution 4(c) exclude 2,390,000 votes cast by Canaccord and FSB, or their associates, which are to be issued Broker Warrants. The excluded votes are reclassified to votes withheld/abstain, resulting in no change to the total Shares being voted in connection with Resolution 4(c).
Resolution 4(d): Total votes for Resolution 4(d) exclude 468,854 votes cast by parties participating in the SPP. The excluded votes are reclassified to votes withheld/abstain, resulting in no change to the total Shares being voted in connection with Resolution 4(d).
Resolution 5: Total votes for Resolution 5 exclude nil votes cast by Orion which is to be issued Orion Warrants.

A total of 35,504,229 common shares, representing approximately 44.09% of the issued and outstanding common shares of the Company eligible to vote at the Meeting, were voted in connection with all of the above resolutions, except for the following: (a) the election of the Mr. Rick Anthon as a director of the Company, for which 35,618,229 common shares, representing approximately 44.23% of the issued and outstanding common shares of the Company eligible to vote at the Meeting were voted; and (b) resolution 2, the appointment of PricewaterhouseCoopers LLP as Auditors of the Company, for which 35,645,599 common shares, representing approximately 44.26% of the issued and outstanding common shares of the Company eligible to vote at the Meeting were voted. The results of all matters considered at the Meeting are reported in the Report of Voting Results as filed by the Company on SEDAR at www.sedarplus.ca.

In accordance with ASX Listing Rule 3.13.2(e), the information below is being provided for the aggregate number of securities for which valid proxies were received before the Meeting. None of the Company appointed proxy holders were able to vote on any of the resolutions in their discretion.

Nominee	Total Proxies Received	Proxy directed to vote For	Proxy directed to vote Against	Proxy directed to Abstain	Proxy could vote at their discretion
Resolution 1 – Election of directors:
John Webster	35,504,229	30,473,634	N/A	5,030,595	Nil
David B. Dreisinger	35,504,229	30,289,601	N/A	5,214,628	Nil
Thomas M. Stepien	35,504,229	30,298,601	N/A	5,205,628	Nil
Ludivine Wouters	35,504,229	33,904,004	N/A	1,600,225	Nil
Rick Anthon	35,618,229	33,735,888	N/A	1,882,341	Nil
Resolution 2 – Appointment of Pricewaterhouse- Coopers LLP as Auditors of the Company	35,645,599	31,760,224	N/A	3,885,375	Nil
Resolution 3 – Re-approval of the Company’s Stock Option Plan ⁽¹⁾	35,504,229	31,933,996	2,963,702	606,531	Nil
Resolution 4(a) – Issuance of 54,113,609 Units comprising 39,463,331 Shares and 14,650,278 CDIs and 54,113,609 Warrants to Non-Related Party Investors and the EBRD⁽²⁾	35,504,229	27,456,337	1,228,296	6,819,596	Nil
Resolution 4(b)(i) – Issuance of 55,555 Units, comprising of 55,555 Shares and 55,555 Warrants, to JJW Investments Ltd.⁽³⁾	35,504,229	33,171,670	1,235,052	1,097,507	Nil
Resolution 4(b)(ii) – Issuance of 41,666 Units, comprising of 41,666 Shares and 41,666 Warrants, to Dr. David B. Dreisinger⁽⁴⁾	35,504,229	33,187,967	1,235,052	1,081,210	Nil
Resolution 4(b)(iii) – Issuance of 55,555 Units, comprising of 55,555 Shares and 55,555 Warrants, to Mr. Thomas M. Stepien	35,504,229	33,407,649	1,235,052	861,528	Nil
Resolution 4(b)(iv) – Issuance of 55,555 Units, comprising of 55,555 Shares and 55,555 Warrants, to Ms. Ludivine Wouters	35,504,229	33,196,678	1,234,188	1,073,363	Nil
Resolution 4(b)(v) – Issuance of 256,410 Units, comprising of 256,410 CDIs and 256,410 Warrants, to Mr. Rick Anthon	35,504,229	33,469,602	1,234,188	800,439	Nil
Resolution 4(c) – the issuance of 4,904,478 Broker Warrants to Canaccord and FSB⁽⁵⁾	35,504,229	30,898,394	1,163,498	3,442,337	Nil
Resolution 4(d) – the issuance of 7,692,307 CDIs and 7,692,307 Warrants to Eligible Shareholders under the SPP⁽⁶⁾	35,504,229	33,324,730	906,086	1,273,413	Nil
Resolution 5 – the issuance of 22,263,733 Orion Warrants to Orion	35,504,229	33,362,546	1,184,924	956,759	Nil

⁽¹⁾ Excludes 455,661 votes cast by proxy by directors of the Company, which were reclassified as withheld/abstain.
⁽²⁾ Excludes 6,527,532 votes cast by proxy by the EBRD, directors and other subscribers in the Offering, which were reclassified as withheld/abstain.
⁽³⁾ Excludes 235,979 votes cast by proxy by John Webster and companies controlled by him (including JJW Investments Ltd.), which were reclassified as withheld/abstain.
⁽⁴⁾ Excludes 219,682 votes cast by proxy by David Dreisinger and companies controlled by him, which were reclassified as withheld/abstain.
⁽⁵⁾ Excludes 2,390,000 votes cast by proxy by Canaccord and FSB or their associates, which were reclassified as withheld/abstain.
⁽⁶⁾ Excludes 468,854 votes cast by proxy by subscribers to the SPP, which were reclassified as withheld/abstain.

Change in Chief Financial Officer

The Company also announces that Dean Larocque will step down as Chief Financial Officer effective May 30, 2025. The Company would like to thank Dean for his efforts since joining the Company in November 2024 and wish him well in his future endeavours. The Company expects to announce the appointment of its new Chief Financial Officer in the coming weeks.

About Euro Manganese

Euro Manganese is a battery materials company focused on becoming a leading producer of high-purity manganese for the electric vehicle industry. The Company is advancing development of the Chvaletice Manganese Project in the Czech Republic and an early-stage opportunity to produce battery-grade manganese products in Bécancour, Québec.

The Chvaletice Project is a unique waste-to-value recycling and remediation opportunity involving reprocessing old tailings from a decommissioned mine. It is also the only sizable resource of manganese in the European Union, strategically positioning the Company to provide battery supply chains with critical raw materials to support the global shift to a circular, low-carbon economy.

Euro Manganese is dual-listed on the TSXV and the ASX.

Authorized for release by the President and CEO of Euro Manganese Inc.

Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) or the ASX accepts responsibility for the adequacy or accuracy of this release.

Inquiries

Martina Blahova
President and CEO
+1-604-681-1010 ext. 101
Website: www.mn25.ca

Laurel Petryk
Chief Legal Officer & Corporate Secretary
+1-604-681-1010

LodeRock Advisors
Neil Weber
Investor and Media Relations – North America
+1 (647) 222-0574 neil.weber@loderockadvisors.com

Jane Morgan Management
Jane Morgan
Investor and Media Relations – Australia
+61 (0) 405 555 618
jm@janemorganmanagement.com.au

Company Address: #709 -700 West Pender St., Vancouver, British Columbia, Canada, V6C 1G8

Forward-Looking Statements

Certain statements in this news release constitute “forward-looking statements” or “forward-looking information” within the meaning of applicable securities laws. Such statements and information involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance, or achievements of the Company, its Chvaletice Project, or industry results, to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or information. Such statements can be identified by the use of words such as “may”, “would”, “could”, “will”, “intend”, “expect”, “believe”, “plan”, “anticipate”, “estimate”, “scheduled”, “forecast”, “predict” and other similar terminology, or state that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved.

Readers are cautioned not to place undue reliance on forward-looking information or statements. Forward-looking statements are subject to a number of risks and uncertainties that may cause the actual results of the Company to differ materially from those discussed in the forward-looking statements and, even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, the Company.

Forward-looking statements include statements regarding replacing the Chief Financial Officer and any expected outcome and ability to navigate current market conditions. All forward-looking statements are made based on the Company’s current beliefs including various assumptions made by the Company, including that the Chvaletice Project will be developed and operate as planned, the Company will obtain sufficient financing, and that the Company will be able to meet the conditions of its secured financing. Factors that could cause actual results or events to differ materially from current expectations include, among other things: insufficient working capital; inability to meet the conditions of its secured financing, risks due to granting security, lack of availability of financing for developing and advancing the Chvaletice Project; the potential for unknown or unexpected events to cause contractual conditions to not be satisfied; developments in EV (Electric Vehicles) battery markets and chemistries; risks related to fluctuations in currency exchange rates; and regulation and changes in laws by various governmental agencies. For a further discussion of risks relevant to the Company, see “Risk Factors” in the Company’s annual information form for the year ended September 30, 2024, available on the Company’s SEDAR+ profile at www.sedarplus.ca.

Although the forward-looking statements contained in this news release are based upon what management of the Company believes are reasonable assumptions, the Company cannot assure investors that actual results will be consistent with these forward-looking statements. These forward-looking statements are made as of the date of this news release and are expressly qualified in their entirety by this cautionary statement. Subject to applicable securities laws, the Company does not assume any obligation to update or revise the forward-looking statements contained herein to reflect events or circumstances occurring after the date of this news release.

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/252349

TruMerit Hails Release of WHO’s State of the World’s Nursing Report

TruMerit™ (formerly CGFNS International) welcomed the release this week of the World Health Organization’s State of the World’s Nursing Report, which provides the first comprehensive assessment of global nursing since the COVID-19 pandemic.

The report highlights a critical imperative to strengthen global nursing capacity in the wake of the pandemic and amid economic uncertainty, climate change impacts, and persistent health inequities. It warns that the global health workforce shortage will continue to widen, reaching 11 million by 2030, thereby requiring a fundamental shift in how countries approach healthcare workforce planning and investment.

While emphasizing the urgent need to address this challenge, TruMerit President and CEO Dr. Peter Preziosi, who served on the WHO steering committee that helped guide the report’s preparation, pointed to opportunities to leverage the power of nursing to resolve inequities and shore up healthcare delivery and quality around the world.

“In response to this report, non-governmental organizations in the healthcare sector must adopt collaboration as their watchword and work with each other and with professional societies and patient-centered organizations in pursuing genuine social impact,” said Preziosi. “We need to support next-generation approaches that recognize the critical role of nurses – who make up the largest segment of the global healthcare workforce – in advancing primary care, resilient health systems, and universal health coverage solutions to optimize population health in every country.”

“As the report points out, nearly 80% of the world’s nurses are working in countries that cover only half the world’s population. This is a critical imbalance in the global nursing workforce that must be addressed. We can help do that with a greater focus on scaling up high-quality nursing education and career development that expands across borders to enable nurses everywhere to deliver on their potential,” he added.

Preziosi also noted these opportunities highlighted in the report:

Progress in the expansion of nurse-led care models, with more than 60% of countries now having introduced Advanced Practice Nursing. By enhancing localized, specialized care, these models are proven to deliver cost-effective care and offer a way forward in expanding health coverage and healthcare equity.
The nursing profession globally is becoming more skilled and prepared, with 80% of the world’s nurses now at the “professional” level. The challenge ahead, said Preziosi, is to ensure they have opportunities to work at the full extent of their education, which requires regulatory frameworks to be strengthened and modernized to reflect updated scopes of practice and relevant continuing professional development.
The wider use of digital health tools is bringing expert consultations to remote areas, including those powered by telehealth and artificial intelligence. These are showing great promise in enhancing accessibility and bridging gaps in care delivery, invigorating nursing education, and improving efficiency, accessibility, and outcomes.

Seizing on these and other opportunities highlighted in the report, Preziosi expressed optimism that the grave challenges posed by the nursing shortage and other factors can be addressed.

“When the people who deliver the care are empowered with the knowledge, tools, and inspiration to achieve excellence in their profession, they can lead the way to resolving the healthcare challenges of today and tomorrow,” he said.

Click here to access the WHO State of the World’s Nursing report.

About TruMerit
TruMerit is a worldwide leader in healthcare workforce development. Formerly known as CGFNS International, the organization has a nearly 50-year history supporting the career mobility of nurses and other healthcare workers – and those who license and hire them – by validating their education, skills, and experience as they seek authorization to practice in the United States and other countries. As TruMerit, this mission has been expanded to building workforce capacity that meets the needs of people in a rapidly evolving global health landscape. Through its Global Health Workforce Development Institute, the organization is advancing evidence-based research, thought leadership, and advocacy in support of healthcare workforce development solutions, including globally recognized practice standards and certifications that will enhance career pathways for healthcare workers.

Contact Information
David St. John
dstjohn@trumerit.org

SOURCE: TruMerit

Related Images

Global Sports Brand U.S. Polo Assn. Launches Menswear in Argentina

U.S. Polo Assn., the official brand of the United States Polo Association (USPA), is proud to announce its launch in the Argentine market alongside its brand partners Incom S.p.a. and Sur Pacifico S.A. This entry further enhances the multi-billion-dollar brand’s global presence and expands U.S. Polo Assn.’s reach into another new and exciting market.

The global sports brand’s presence in Argentina will focus on a territory steeped in history, where the sport of polo is not only widely celebrated but also deeply rooted in the local culture. U.S. Polo Assn. will commence with the launch of the men’s collection in June 2025, featuring timeless styles such as polo shirts, woven shirts, t-shirts, trousers, jeans, knitwear, and jackets.

“Partnering with Incom S.p.a. and Sur Pacifico S.A. to bring the U.S. Polo Assn. brand to Argentina for the first time-a country with a profound polo legacy and amazing consumers-is a significant milestone,” said J. Michael Prince, President and CEO of USPA Global, the company that manages and oversees the multi-billion-dollar global U.S. Polo Assn. brand. “This opportunity has the potential for U.S. Polo Assn. to be one of the most influential sport-inspired brands in the entire marketplace.”

Sur Pacifico S.A. is an Argentine company founded in 1985. With a solid business and brand background, it has established itself in the textile clothing market, initially focusing on men’s and children’s apparel and more recently expanding to women’s fashion. Since 1992, Sur Pacifico S.A. has been the exclusive licensee of the Mistral brand, a Dutch-origin brand originally linked to water sports, particularly surfing. The company also manages two international brands, Brooksfield and Royal Einfield Apparel.

“We are thrilled to have found a strategic partner in Argentina, such as Sur Pacifico S.A., who aligns with our values, allowing us to bring the U.S. Polo Assn. brand to a market historically connected to the sport of polo,” says Lorenzo Nencini, CEO of Incom. “This unique collaboration will allow us to reach new, passionate consumers and strengthen U.S. Polo Assn.’s authentic connection within the world of sports, creating a perfect synergy between the brand’s heritage and the excellence of this discipline in Argentina.”

ABOUT U.S. POLO ASSN.
U.S. Polo Assn. is the official brand of the United States Polo Association (USPA), the largest association of polo clubs and polo players in the United States, founded in 1890 and based at the USPA National Polo Center in Wellington, Florida. This year, U.S. Polo Assn. celebrates 135 years of sports inspiration alongside the USPA. With a multi-billion-dollar global footprint and worldwide distribution through more than 1,100 U.S. Polo Assn. retail stores as well as thousands of additional points of distribution, U.S. Polo Assn. offers apparel, accessories, and footwear for men, women, and children in more than 190 countries worldwide. Historic deals with ESPN in the United States and Star Sports in India now broadcast several of the premier polo championships in the world, sponsored by U.S. Polo Assn., making the thrilling sport accessible to millions of sports fans globally for the very first time.

U.S. Polo Assn. has consistently been named one of the top global sports licensors in the world alongside the NFL, NBA, and MLB, according to License Global. In addition, the sport-inspired brand is being recognized internationally with awards for global and digital growth. Due to its tremendous success as a global brand, U.S. Polo Assn. has been featured in Forbes, Fortune, Modern Retail, and GQ as well as on Yahoo Finance and Bloomberg, among many other noteworthy media sources around the world.

For more information, visit uspoloassnglobal.com and follow @uspoloassn.

ABOUT INCOM S.P.A.
Incom S.p.a., founded in Montecatini Terme (PT) in 1951, operates under license as the clothing division of the U.S. Polo Assn. brand and also produces and distributes important clothing brands worldwide. Additionally, Incom S.p.a. is one of the main suppliers of military and paramilitary clothing for the Italian State, providing both uniforms and technical apparel made with the special proprietary patent “Float” for floating garments. Since January 2008, Incom S.p.a. has been producing and distributing men’s, women’s, children’s, underwear, and swimwear clothing under the U.S. Polo Assn. brand in Europe, with consistently growing sales results. For more information, visit www.incomitaly.com.

Contact Information
Paola Varani
HUB PRESS OFFICE
paolavarani@hubcomm.net

Laura Varani
HUB PRESS OFFICE
lauravarani@hubcomm.net

Stacey Kovalsky
VP, Global PR and Communications, USPA Global
skovalsky@uspagl.com
+001.561.790.8036

Alesia Lana
Marketing & Communications, Incom S.p.a.
a.lana@incomitaly.com

Camilla Donati
HUB PRESS OFFICE
camilladonati@hubcomm.net

SOURCE: U.S. Polo Assn.

International Medical and Healthcare Week Highlights Hong Kong’s Strengths in Medical and Innovation

– Asia Summit on Global Health and Medical and Healthcare Fair run concurrently

– The 5th Asia Summit on Global Health launches new Silver Health Chapter, focusing on innovations in anti-ageing and enhancing healthcare for the elderly.
– The 16th Hong Kong International Medical and Healthcare Fair serves as a comprehensive platform to foster global collaborations, attracting some 300 exhibitors to showcase cutting-edge medical technologies, gerontechnology and green solutions.

The fourth International Healthcare Week (IHW), coordinated by the Hong Kong Trade Development Council (HKTDC), will take place from 26 May to 15 June. The IHW’s flagship events, the Asia Summit on Global Health (ASGH), jointly organised by the HKSAR Government and HKTDC, will be held at the Hong Kong Convention and Exhibition Centre (HKCEC) on 26 and 27 May while the Hong Kong International Medical and Healthcare Fair (Medical Fair), organised by the HKTDC and co-organised by the Hong Kong Medical and Healthcare Device Industries Association (HKMHDIA), will run concurrently from 26 to 28 May, highlighting Hong Kong’s position as a leading regional healthcare hub.

Margaret Fong, Executive Director of the HKTDC, said: “As a global hub for medical innovation, Hong Kong serves as both a ‘super-connector’ and a ‘super value-adder’, driving regional collaboration to advance healthcare innovation and foster new quality productivity in biopharmaceutical technologies. At the same time, there are pressing global public health challenges, such as an ageing population and the rising prevalence of chronic diseases, which are intensifying healthcare demand. To address these challenges, the industry is actively embracing innovative technologies to upgrade and transform the healthcare sector. This year’s ASGH introduces a dedicated Silver Health Chapter, with both ASGH and the Medical Fair highlighting healthy ageing and elderly health innovations. The HKTDC will continue to serve as a platform for cross-sector collaboration supporting industry-academia-research partnership in fields including biotechnology, digital healthcare, and smart elderly wellness. We look forward to bringing together local and global experts, investors, enterprises, and institutions through ASGH and Medical Fair, injecting new vitality into the Asian healthcare industry and shaping the future of the medical sector.”

Global expertise shapes the future of healthcare
Themed Fostering Global Collaboration for a Shared Future, the 5th ASGH reaffirms Hong Kong’s pivotal role as a leading MedTech hub in the region. Through diverse elements such as the ASGH Business Hub, ASGH connects global healthcare innovators, investors, and project owners on a single platform, acting as a catalyst for potential partnerships. Government officials and organisations, research pioneers, investors, and business leaders from the global healthcare sector will also share insights on industry trends and explore collaboration opportunities among Hong Kong, Mainland China, and global enterprises in healthcare investment and innovation.

Dr Peter K N Lam, Chairman of the HKTDC, will deliver welcome remarks, while John Lee, Chief Executive of the HKSAR will give opening remarks, and Prof Cao Xuetao, Vice-Minister of the National Health Commission of the People’s Republic of China, will give special remarks on the first day of ASGH.

The first session of the ASGH Plenary Sessions will commence on the opening day and focus on building a more equitable and sustainable healthcare system and explore how innovative policymaking and strengthened international collaboration can foster healthcare systems that are both resilient and inclusive to address emerging global health challenges. Prof Lo Chung-mau, HKSAR Government’s Secretary for Health, will deliver the special remarks and will be joined by an esteemed panel of speakers, including Prof Tsui Lap-chee, Chairman of the University of Hong Kong Foundation for Educational Development and Research; Prof Nancy Ip, President of the Hong Kong University of Science and Technology; Mr Frédéric Rimattei, Special Envoy for International Affairs of the President of French University Hospitals National Association; Dr Wu Xiaobin, Vice President of China Pharmaceutical Innovation and Research Development Association; and Mr Martin Taylor, Representative to China of World Health Organisation.

At the second plenary, speakers will examine how global stakeholders can collaborate to navigate the current economic and healthcare innovation landscape while identifying new investment and market opportunities in the health sector. The session will be chaired by Mr Victor Chu, Chairman & CEO of First Eastern Investment Group, featuring Ambassador George Hara, Group Chairman and CEO of DEFTA Partners; Prof Ng Siew-chien, Croucher Professor in Medical Sciences and Associate Dean (Research) of Faculty of Medicine of the Chinese University of Hong Kong; Dr Hiroaki Ueno, Representative Director of Mitsubishi Tanabe Pharma Corporation and Dr Prem Kumar Nair, Group Chief Executive Officer of IHH Healthcare Berhad.

During the Dialogue with Global Pioneer in Health session, Prof John Hardy, Chair of Molecular Biology of Neurological Disease of UCL Queen Square Institute of Neurology, will share his insights on his groundbreaking work on emerging therapeutic approaches to neurodegenerative diseases. Prof Hardy was awarded the Breakthrough Prize and received the Brain Prize for “groundbreaking research on the basis of Alzheimer’s disease”.

Inaugural Silver Health Chapter: Navigating ageing’s challenges & opportunities
Amidst the global demographic shift toward ageing populations, this year’s ASGH proudly inaugurates a dedicated “Silver Health Chapter” aimed at critically examining the multifaceted challenges and transformative opportunities presented by ageing societies. On the second day, a session titled Surfing the Silver Tsunami: Advancements in Geriatrics and Longevity Technology, will bring together experts including Prof Jean Woo, Director of CUHK Jockey Club Institute of Ageing of the Chinese University of Hong Kong; Dr Donald Li, Chairman of Elderly Commission; Dr Alexandra Bause, Co-Founder & Venture Partner of Apollo Health Ventures; Mr Olivier Dessajan, General Manager of China Merchants Colisée; Prof James L. Kirkland, Director of Center for Advanced Gerotherapeutics of Cedars-Sinai; and Dr Sanja Tomovska, Founder and CEO of Quant Biomarkers. This distinguished assembly will present groundbreaking developments in geroscience, while critically evaluating emerging investment paradigms within the global longevity economy.

On the same day, global industry leaders will convene for a dedicated session titled The Next Wave of Innovations in Neuroscience, examining cutting-edge advancements and emerging trends in neurological science, including novel therapeutic approaches for Parkinson’s disease and related disorders. Concurrently, the InnoHealth Showcase will feature healthcare investment projects specifically designed to address the needs of ageing populations, presenting data-driven approaches to mitigate the challenges of demographic ageing.

During ASGH, Ms Anita Ou, Managing Director and Head of Enterprise Banking of HSBC; Dr Kenneth Tsang, Regional Chief Executive Officer of IHH Healthcare North Asia and Chief Executive Officer of Gleneagles Hospital Hong Kong; Prof Zhang Weixiong, Associate Director of Academy for Interdisciplinary Research (PAIR) of The Hong Kong Polytechnic University; Dr Sarah Salvilla, Group Chief Health Officer of FWD Group, will share their insights on achieving “Healthy China 2030,” the high quality development of the healthcare industry, data-driven healthcare, and new collaborative models for the healthcare sector. ASGH will also address trending topics in the healthcare industry, including the prospects of gene and cell therapies, women’s health, the convergence of Chinese and Western medicine, cancer treatment, orphan drugs, and rare diseases.

ASGH, in collaboration with the Hong Kong University of Science and Technology, will host two sessions under the overarching theme “Shaping the Future of Healthcare”. These sessions will focus on the potential of artificial intelligence in the medical field and how innovative technologies can drive breakthroughs in healthcare. Featured speakers include Dr Alex Ng, President of Tencent Healthcare; Prof Graham Cooke, Vice-Dean (Research) of the Faculty of Medicine of Imperial College London; Prof Chen Hao and Prof Bonnie Zhu, Assistant Professors of the Hong Kong University of Science and Technology.

ASGH deal-making bridges investors and project owners
The ASGH deal-making facilitates one-on-one meetings both online and offline, aiming to connect investors and projects in the healthcare sector from around the world to promote global collaborations. Participating investors represent a diverse range of backgrounds, including angel investors, venture capital, corporate venture capital, private equity, family offices and more. Investment interests span pharmaceuticals, medical devices and diagnostics, AI and digital health, and community health and wellness.

The ASGH Business Hub features more than 170 innovative technology companies from 13 countries and regions, including dedicated pavilions from the mainland (Shanghai and Xiamen), Australia, and Thailand. The InnoHealth Showcase area highlights more than 70 healthcare start-ups and projects, many of which have received awards, and is led by the Innovation and Technology Commission in collaboration with six local universities and Cyberport.

Medical Fair facilitates industry collaboration
Themed as the Innovations Boosting Smart Health Experience, the 16th Medical Fair will be held from 26 to 28 May, and welcomes some 300 exhibitors from 13 countries and regions. In addition to pavilions and exhibitors from Hong Kong, Mainland China, Taiwan, Japan, Korea and Hungary, there are also pavilions from Israel, Thailand, and the United Kingdom participating for the first time, along with debut exhibitors from Germany, Italy, Luxembourg and Singapore..

The Medical Fair serves as an excellent platform for professionals worldwide, encompassing research and development institutions, manufacturers, public healthcare organisations, hospitals, clinics, distributors, and healthcare practitioners. This event facilitates the establishment of global business connections and provides valuable insights into the latest trends in the healthcare industry. The exhibition features the HKMHDIA Pavilion, as well as Biotechnology, Hospital Equipment, Rehabilitation and Elderly Care Products, and Startup zones.

This year’s Medical Fair highlights three major areas: cutting-edge medical technologies, gerontechnology, and green solutions, featuring the latest medical health devices, products, and applications, with a particular emphasis on medical diagnostics, innovations in smart hospitals, and digital health solutions.

One exhibitor will showcase a solution that uses advanced computer vision and artificial intelligence to analyse data from patients with facial paralysis and swallowing difficulties. By matching patients with the most suitable rehabilitation programmes from a database of more than 400 training exercises, the solution provides therapists personalised treatment suggestions to refine and adopt. Another exhibitor introduces medical-grade digital therapy solutions for cognitive impairments, leveraging AI to assess patient conditions and deliver customised rehabilitation programs. Further innovations include a handheld medical device for cervical examinations, which analyses cervical tissue to aid in the detection and prevention of preterm births.

The Hong Kong Council of Social Service will make its inaugural participation at the Medical Fair, presenting age-friendly technologies and products including rehabilitation and mobility aids, cognitive impairment support systems, and smart home innovations. Additionally, other exhibitors will showcase sustainable products, such as eco-conscious eating bibs crafted from recycled plastic bottles and biodegradable medical trays.

The Medical Fair features a strong line-up of leading research and academic institutions, including seven local universities, over 30 innovative technology companies at the Hong Kong Science and Technology Parks Corporation (HKSTP) pavilion, and more than 20 medical enterprises brought by the Hong Kong Medical and Healthcare Device Industries Association (HKMHDIA). The event will actively promote innovation and collaboration across government, industry, academia, research and investment sectors.

Multiple activities will be held during the Medical Fair to help industry professionals expand their knowledge of the latest market information. The HKMHDIA Medical Fair Forum themed “The MedTech Nexus of the Greater Bay Area” features industry experts sharing their insights on topics such as intellectual property protection strategies for biomedical innovation, cross-border financial solutions for medical enterprises, the development of cross-border health data, and successful experiences in promoting medical technology in the Greater Bay Area.

“The Latest Development of Regulatory Collaboration on Medical Devices in the Greater Bay Area” seminar will bring together representatives from the Greater Bay Area Center for Medical Device Evaluation and Inspection of the National Medical Products Administration, the Department of Health, and industry leaders to discuss the latest developments, administrative systems, and regulations.

Using the HKTDC EXHIBITION+ hybrid model, the physical fair from 26 to 28 May is complemented by the Click2Match smart business matching platform, via which buyers can extend their sourcing journey from 19 May to 4 June.

Aside from ASGH and the Medical Fair, IHW also features the Hospital Authority Convention, among many other industry events.

Websites
International Healthcare Week: https://internationalhealthcareweek.hktdc.com/en

Asia Summit On Global Health: https://www.asiasummitglobalhealth.com/conference/asgh/en
Programme: https://www.asiasummitglobalhealth.com/conference/asgh/en/programme
Speakers: https://www.asiasummitglobalhealth.com/conference/asgh/en/speaker

Hong Kong International Medical and Healthcare Fair:
https://www.hktdc.com/event/hkmedicalfair/en
List of products: https://www.hktdc.com/event/hkmedicalfair/en/product
Activity schedule: https://www.hktdc.com/event/hkmedicalfair/en/intelligence-hub

Members of the media interested in interviewing ASGH speakers, please send requests to tleung@yuantung.com.hk on or before 20 May 2025

Media enquiries
For enquiries, please contact Yuan Tung Financial Relations Limited:

Louise Song	Tel: (852) 3428 5691	Email: lsong@yuantung.com.hk
Tiffany Leung	Tel: (852) 3428 2361	Email: tleung@yuantung.com.hk

HKTDC’s Communications & Public Affairs Department:
Asia Summit on Global Health

Sharon Ha	Tel: (852) 2584 4575	Email: sharon.mt.ha@hktdc.org
Katy Wong	Tel: (852) 2584 4524	Email: katy.ky.wong@hktdc.org
Jane Cheung	Tel: (852) 2584 4137	Email: jane.mh.cheung@hktdc.org

Hong Kong International Medical and Healthcare Fair

Kelly Shek	Tel: (852) 2584 4537	Email: kelly.yt.shek@hktdc.org
Clayton Lauw	Tel: (852) 2584 4472	Email: clayton.y.lauw@hktdc.org

Media Room: http://mediaroom.hktdc.com

About HKTDC
The Hong Kong Trade Development Council (HKTDC) is a statutory body established in 1966 to promote, assist and develop Hong Kong’s trade. With over 50 offices globally, including 13 in Mainland China, the HKTDC promotes Hong Kong as a two-way global investment and business hub. The HKTDC organises international exhibitions, conferences and business missions to create business opportunities for companies, particularly small and medium-sized enterprises (SMEs), in the mainland and international markets. The HKTDC also provides up-to-date market insights and product information via research reports and digital news channels. For more information, please visit: www.hktdc.com/aboutus.

African Mining Giant Intends to List in Hong Kong to Build West African Gold Leader

In Africa, a land of opportunity and potential, a mining company is emerging and its plan to go public has caught the attention of the global capital markets. According to authoritative sources, the Company has successfully acquired the mining rights of three major mining areas in West Africa. Recent exploration results show that its potential gold reserves are as high as 3,000 tons, with a preliminary valuation of HK$1.2 trillion, demonstrating enormous development potential and expecting to reshape the pattern of the global mining industry.

Corporate Profile and Listing Plan
The Company plans to list on the Hong Kong Stock Exchange or an overseas capital market and intends to issue approximately 120 billion shares to raise funds to further strengthen its position in the global mining market. The Company, which is 25% owned by the country in which it is located, is positioned as the largest gold mining group in West Africa and is committed to driving regional economic prosperity and increasing its international presence.

Social Responsibility and Development Plan
The Company not only focuses on economic benefits, but also demonstrates a strong sense of social responsibility. After the listing, it is expected that 20% of the shares will be used for employee incentive scheme to realize the vision of “Wealth for All”, while another 5% will be used for subsequent financing and business development to support the sustainable development of the Company and technological innovation.

Industry Evaluation and Future Prospects
Industry insiders analyse that the Company is expected to become a “rising star” in the global mining industry with its abundant mineral resources, clear strategic planning and commitment to social responsibility. The future performance of the African mining giant will undoubtedly be a focus for the capital markets as it moves forward with its listing plan.

Business delegation concludes Middle East mission in Kuwait

– 59 MoUs and announcements facilitated to enhance HK’s role as superconnector and super value-adder

– A delegation led by Mr John Lee, Chief Executive of the Hong Kong Special Administrative Region, visited Kuwait as part of a broader high-level visit to the Middle East
– The delegation explored the Middle Eastern market and supported high-quality Belt and Road cooperation while promoting Hong Kong’s unique role as a superconnector and super value-adder
– A total of 59 MoUs and announcements were facilitated during the mission, cultivating deeper partnerships between Hong Kong, the mainland, Qatar, and Kuwait

A business delegation led by Mr John Lee, Chief Executive of the Hong Kong Special Administrative Region (HKSAR), and organised by the Hong Kong Trade Development Council (HKTDC) visited Kuwait City on 12-15 May, successfully concluding a five-day mission to Qatar and Kuwait.

A total of 59 MoUs and announcements were facilitated during the mission with the aim to cultivate deeper partnerships and create new opportunities for synergy between Hong Kong, the mainland, Qatar, Kuwait and the broader Middle Eastern market. The mission also successfully enhanced collaboration between Hong Kong and the mainland, enabling mainland companies to partner with Hong Kong businesses to expand into the Middle East and beyond.

Over the past few days, the delegation, comprising over 50 business leaders from Hong Kong and enterprise representatives from seven mainland provinces and cities, explored the Middle Eastern market and supported high-quality Belt and Road cooperation while promoting Hong Kong’s unique role as a superconnector and super value-adder.

During the visit to Kuwait, 24 memoranda of understanding (MoUs) and announcements were facilitated in trade and investment promotion, finance, law, transport and logistics, innovation and technology (I&T), agriculture, education and sport.

The delegation met with senior executives and key members of the Kuwait Investment Authority (KIA), conglomerate Bukhamseen Group Holding and the Kuwait Chamber of Commerce and Industry (KCCI) to discuss investment opportunities and potential collaborations.

The delegation also met with several representatives from the Kuwait Direct Investment Promotion Authority (KDIPA) to gain an in-depth understanding of the operations of Kuwait’s free trade zones. The meeting explored potential cooperation opportunities in areas such as logistics, manufacturing, distribution, and technology.

The delegation visited the Sheikh Abdullah Al Salem Cultural Centre to gain a comprehensive overview of Kuwaiti history, culture and achievements.

To foster cooperation, the Hong Kong Economic and Trade Office (HKETO) and Hong Kong Trade Development Council (HKTDC) organised a high-level business luncheon, which was attended by some 270 business leaders and key officials.

Concluding the Middle East mission, Mr Lee said the delegation, comprising Hong Kong and mainland business leaders, had achieved three key objectives: 1. To strengthen government-to-government relations; 2. To find new areas of collaboration; and 3. To make friends, and expand networks. “Over the past four days, I have observed that both Qatar and Kuwait are experiencing rapid development, supported by substantial investment and continually expanding economies. In meetings with leaders and officials, I appreciated their forward-looking vision and understanding of Hong Kong’s unparalleled advantages under ‘one country, two systems’ as a bridge between the mainland and the world. As Middle Eastern countries seek diversification of risk and look for opportunities in China and the Hong Kong SAR to join the tide of the global economic shift towards the East, Hong Kong has boundless opportunities.”

He pointed out that this visit will elevate the relationship between Hong Kong and Qatar and Kuwait to a new level, bringing more business opportunities to Hong Kong, and noted, “We will continue to strive to explore new opportunities and frontiers for Hong Kong.”

Dr Peter K N Lam, Chairman of the HKTDC, said: “Over the past few days, we engaged in high-level government and business meetings, hosted business luncheons and visited key development projects in Qatar and Kuwait. We explored how Qatari and Kuwaiti businesses can leverage Hong Kong’s advantages in finance, innovation and technology and professional services to advance intiatives in finance, energy transformation and smart infrastructure projects, contributing to the Qatar National Vision 2030 and Kuwait Vision 2035.”

“Following the visits, the HKTDC will continue to invite business leaders from the Middle East to visit Hong Kong. We welcome them participating in our international events, such as the Belt and Road Summit and Asian Financial Forum to explore opportunities in Hong Kong, Mainland China and beyond,” Dr Lam added.

24 MoUs and announcements were facilitated in Kuwait by the government and the following members of the delegation:
1.Invest Hong Kong and Kuwait Direct Investment Promotion Authority (KDIPA)
2.Agriculture, Fisheries and Conservation Department and Marine Science Centre of Kuwait University (Announcement)
3.Agriculture, Fisheries and Conservation Department and Public Authority of Agriculture Affairs and Fish Resources (Announcement)
4.Hong Kong Customs and Excise Department and Kuwait General Administration of Customs (Announcement)
5.Airport Authority Hong Kong (AAHK) and Kuwait Airways (Announcement)
6.Belt and Road General Chamber of Commerce and Kuwait Chamber of Commerce & Industry (KCCI)
7.Federation of Hong Kong Industries (FHKI) and Kuwait Chamber of Commerce & Industry (KCCI)
8.Hong Kong General Chamber of Commerce (HKGCC) and Kuwait Chamber of Commerce & Industry (KCCI)
9.Hong Kong Trade Development Council (HKTDC) and Kuwait Chamber of Commerce & Industry (KCCI)
10.Hong Kong Trade Development Council (HKTDC) and Kuwait Direct Investment Promotion Authority (KDIPA)
11.Sports Federation & Olympic Committee of Hong Kong, China and Olympic Council of Asia
12.The Chinese Manufacturers’ Association of Hong Kong (CMA) and Kuwait Chamber of Commerce & Industry (KCCI)
13.The Law Society of Hong Kong and Kuwait Bar Association
14.Financial Services Development Council (FSDC) and Capital Market Authority in Kuwait (CMA) (non-delegate)
15.City University of Hong Kong and Ministry of Higher Education
16.City University of Hong Kong and Kuwait University
17.Templewater and Blue Ocean Company
18.Deloitte China and Baoye Hubei Construction Engineering Group Co., Ltd
19.Deloitte China and PCI Technology Co., Ltd
20.HSBC and PCI Technology Co., Ltd
21.HSBC and Meetsocial Group
22.Templewater and Shanghai Westwell Technology
23.Templewater and Shanghai Fengling Renewables Co., Ltd
24.Dongchao Information Technology (Shanghai) Co., Ltd and Kuwait Direct Investment Promotion Authority (KDIPA)

Earlier during the mission, 35 MoUs and announcements were facilitated in Qatar:
1.Federation of Hong Kong Industries (FHKI) and Qatar Chamber of Commerce & Industry (QCCI)
2.Hong Kong General Chamber of Commerce (HKGCC) and Qatar Chamber of Commerce & Industry (QCCI)
3.Hong Kong Tourism Board (HKTB) and Qatar Airways
4.Hong Kong Trade Development Council (HKTDC) and Invest Qatar
5.Hong Kong Trade Development Council (HKTDC) and Qatari Businessmen Association (QBA)
6.Hong Kong Trade Development Council (HKTDC) and Qatar Chamber of Commerce & Industry (QCCI)
7.Hong Kong Trade Development Council (HKTDC) and Qatar Financial Centre (QFC)
8.The Chinese Manufacturers’ Association of Hong Kong (CMA) and Qatari Businessmen Association (QBA)
9.The Hong Kong Associations of Bank and Qatar Chamber of Commerce & Industry (QCCI)
10.The Law Society of Hong Kong and Qatar International Center for Conciliation and Arbitration (QICCA)
11.The Law Society of Hong Kong and Qatar Lawyers Association
12.Financial Services Development Council (FSDC) and Qatar Financial Centre (QFC) (non-delegate)
13.Hang Seng Indexes Company Limited and Qatar Financial Centre (QFC)
14.MTR Corporation Limited and Qatar National Bank
15.Belt and Road General Chamber of Commerce and Luyi Industrial Park
16.Hong Kong Productivity Council and Shanghai Westwell Technology
17.Hong Kong Productivity Council and EHang Intelligent Equipment (Guangzhou) Co., Ltd
18.Bank of China (Hong Kong) and Shanghai Westwell Technology
19.Baoye Group and Luyi Industrial Park
20.Deloitte China and Glodon Technology Co., Ltd
21.Deloitte China and WeBank
22.HSBC and PCI Technology Co., Ltd
23.HSBC and Meetsocial Group
24.Standard Chartered and Fosun International
25.Templewater and WeBank
26.Center International Group Co., Limited and Luyi Industrial Development QFZ
27.Luyi Industrial Park and Qatar Development Bank
28.Goldford Group and WeBank and Klickl Technology L.L.C.
29.Development Bureau and Public Works Authority ‘Ashghal’ of Qatar
30.Invest Hong Kong and Qatar Chamber of Commerce & Industry
31.Invest Hong Kong and Qatari Businessmen Association (QBA)
32.Department of Justice and Ministry of Justice of the State of Qatar (Announcement)
33.Hong Kong Customs and Excise Department and Qatar Customs (Announcement)
34.Security Bureau (Announcement)
35.Trade and Industry Department and Ministry of Commerce and Industry of the State of Qatar (Announcement on progress of IPPA’s negotiation)

Photo download: https://bit.ly/4mfLVgf

Media enquiries

HKTDC’s Communications & Public Affairs Department:

Snowy Chan	Tel: (852) 2584 4525	Email: snowy.sn.chan@hktdc.org
Sam Ho	Tel: (852) 2584 4569	Email: sam.sy.ho@hktdc.org

Staying Ahead in the Digital Era as AI Takes Full Center Stage at InfoComm Asia 2025 — Visitor Registration Opens

InfoComm Asia, the premier B2B tradeshow for Professional Audiovisual (Pro AV) and IT professionals and technology end users, announced that visitor registration is now open for its 2025 edition. The event will be held from 23-25 July 2025 at the Queen Sirikit National Convention Center (QSNCC) in Bangkok. This year, Artificial Intelligence (AI) will take center stage, permeating the show floor exhibits, educational Summit sessions, offering attendees an exciting peek into the future of AV, IT and AI integration.

The fifth edition of InfoComm Asia will feature an impressive lineup of 180 global brands, with 40 exhibitors making their debut. Significantly, 75% of these first-time exhibitors hail from China. This underscores a robust wave of Chinese innovation targeting the broader Asian market. Visitors can look forward to experiencing an even broader spectrum of cutting-edge technologies, a more diverse range of solutions and a unique opportunity to connect with these dynamic companies right here at InfoComm Asia.

What’s New and Exciting in 2025 – With AI at the Core

Visitors at InfoComm Asia 2025 will witness AI’s profound impact on Pro AV technology across an expansive three-hall showcase at QSNCC. The deep dive into AI will be evident at the concurrently held 2025 InfoComm Asia Summit.

Illustrating this AI focus, the lineup will feature thought-provoking discussions such as:

The kick-off overview, “Visions of 2030: Reimagining the Future of Business and Technology,”setting the stage for future advancements.
“AI-Powered Employee Experience – What Matters in 2025 and Beyond,” which will delve into how AI is reshaping workplace interactions.
“Blending Innovation with Emotion: How Human-Centric AI is Changing Customer Engagement and Operation Efficiency,” examines AI’s role in enhancing customer relations and operational effectiveness.

The Summit will further dissect AI’s role and impact in specialized areas such as education, broadcast and live event through sessions will specifically address AI’s application in vertical markets like education, broadcast, and live events, with practical insights in talks like “AV & Virtual Production: Unlocking New Creative Horizons” and “AI Audio Mixing: Using it to Gain Advantage.” These are just a few examples of how the Summit will serve as a central hub for understanding and leveraging AI in the Pro AV domain.

New for 2025, InfoComm Asia introduces the AI Tech Application Pitching sessions, a dynamic opportunity for attendees to get direct insight from innovators on how their AI-driven applications are set to tackle industry challenges and shape future market trends.

This focus on tangible AI innovation extends broadly across the InfoComm Asia 2025 show floor. Here, visitors will discover a wide array of market-ready, AI-powered solutions from exhibitors, including:

AI-led IP-based video wall control for control rooms by AVCIT
Video cameras with AI voice tracking and AI gesture recognition for contactless control by AVER
4K Ultra HD camera with AI Intelligent humanoid tracking by KATO
AI-driven computing solutions by SHUTTLE
Camera with AI-based voice tracking technology by LUMENS

Alongside these solutions, visitors can also explore the latest in digital signage, to AI-driven content management systems, smart classroom solutions, ultra-high resolution projection mapping, interactive immersive experiences and more.

Beyond the Tech: Connecting the Industry in a Dynamic World

While the innovative solutions on display are a core attraction, InfoComm Asia 2025 underscores the irreplaceable value of in-person interaction. In a global environment often marked by geopolitical shifts, the opportunity to connect face-to-face, engage in spontaneous discussions, and build trusted professional relationships is more critical than ever. The three-day show serves as a vital hub for the Pro AV community across Asia to not only source for the latest solutions but also to forge meaningful connections, share direct insights, and truly feel the pulse of a dynamic industry in a way that virtual settings cannot replicate.

“InfoComm Asia offers indispensable long-term value, particularly for our AV channel professionals,” says June Ko, Executive Director of InfoComm Asia. “Our show is a prime opportunity to build and nurture the vital human connections that are truly the bedrock of sustained business health. We encourage AV channel professionals and business decision-makers alike to fully leverage this platform to establish new industry contacts, solidify relationships with existing partners, and connect with new peers and potential collaborators. Fostering deep networks and exploring the diverse opportunities available at InfoComm Asia is always a powerful strategic investment in future growth and resilience.”

InfoComm Asia’s Engaging Special Events for Networking, Learning & Insight

To further enrich the visitor experience, InfoComm Asia 2025 is offering a series of engaging special events, prominently featuring its signature off-site Tech Tours. These curated excursions provide attendees with exclusive, behind-the-scenes access to see the latest Pro AV technology in remarkable real-world applications. Highlights include a visit to an advanced virtual production studio designed for the dynamic needs of broadcast, media, and entertainment, and an immersive tour of a premier Bangkok nightclub, showcasing how sophisticated visual displays, advanced audio systems, and integrated lighting design converge to create captivating entertainment experiences.

Complementing these excursions, the show floor itself will be a hub for interaction with additional special events. Visitors are welcome to join dedicated networking receptions, an insightful ‘Lunch & Learn: AI in AV Workshop,’ and the collaborative ‘Regional AV Roundtable & Mixer,’ among others – all curated to provide dynamic opportunities for industry professionals to connect with peers, leaders, and new collaborators. Interested attendees can RSVP for these special events when registering for their InfoComm Asia 2025 show badge via the official website. Some events may be chargeable, and slots are available on a first-come, first-served basis, so early booking is highly recommended.

Visitor Registration for InfoComm Asia 2025 is Now OpenFor full information including details on exhibitors, products and solutions, summit, registration and last remaining booth space and sponsorship opportunities, visit website here.

About InfoCommAsia

InfoCommAsia Pte Ltd. extends its influence through three marquee shows: InfoComm Asia; InfoComm China, Beijing; and InfoComm India. Each show features an exhibition that showcases the world’s most cutting-edge and in-demand professional audiovisual and integrated experience technology solutions and a summit that presents learning opportunities. The shows bring together professional audiovisual industry players and top-level decision-makers from across different markets to tap into the vast potential presented by pro AV solutions.

For more information, visit:

infocomm-asia.com | infocomm-china.com | infocomm-india.com

For media enquiries, please contact:

GlobalAngie Eng, Marketing Director
InfoCommAsia Pte Ltd
angieeng@infocommasia.com

Thailand
Kanokwan Sukchaisri
kanokwan.infocommasia@expointer.net

Quotient Capital’s Strategic Outlook for 2025

Why Fixed Income Is the Smart Money’s Next Move – Quotient Capital’s Strategic Outlook for 2025

With geopolitical tensions, inflation uncertainty, and global capital flows still shifting in response to the Trump administration’s renewed sanctions, fixed income continues to emerge as the strategic asset class for long-term investors. Quotient Capital Pty Ltd has released its 2025 mid-year outlook, showcasing how Australian fixed income is delivering security, stability, and consistent real returns in a turbulent global environment.

Australian Fixed Income: A Beacon of Stability in Volatile Markets
Global markets have been shaken by widespread sanctions introduced by the second Trump administration, prompting turbulence across equities, commodities, and even traditional safe havens. Yet Australia’s fixed income market remains a pillar of strength.

The Reserve Bank of Australia (RBA) forecasts inflation to moderate toward the 2-3% target range by late 2025. Coupled with Australia’s sound credit environment, strong institutional frameworks, and fiscal stability, this positions the domestic bond market as one of the most attractive globally.

Key research insights from Quotient Capital include:

Australian private credit grew by 14% year-on-year (2024-2025).
Domestic corporate bond issuance surged 22% in Q1 2025.
Liquidity across the investment-grade bond market is at its strongest in over a decade.

“Fixed income is no longer just a defensive allocation – it’s a proactive, yield-focused wealth strategy,” said Tom McCallister, Senior Fixed Income Advisor at Quotient Capital.”In this cycle, investors are demanding capital protection, income certainty, and inflation resilience – and Australian bonds deliver all three.”

Geopolitical Shifts and Global Capital Reallocation
The global ripple effects of U.S. sanctions have disrupted cross-border capital flows and credit availability across multiple regions – driving a recalibration among asset allocators.

Australia is benefitting as a preferred destination for investors seeking:

Political neutrality
Robust regulatory governance
High-grade credit assets

“Private wealth, family offices, and institutions are reallocating to Australia with growing conviction,” said James Harrington, Senior Fixed Income Advisor at Quotient Capital.”We offer a unique mix of economic resilience and institutional-grade product access, which is proving incredibly attractive.”

Bringing Institutional Access to Private Investors
Quotient Capital bridges the gap between institutional-grade opportunities and private capital – making it possible for high-net-worth individuals and SMSFs to access premium fixed income products, previously restricted to larger funds.

Tailored solutions include:

Infrastructure-linked debt instruments
Inflation-linked corporate bond portfolios
Private credit notes focused on essential service sectors

All offerings are underpinned by detailed credit analysis, transparent structuring, and clear maturity horizons. Minimum investments typically start at $50,000 AUD.

Strategic Outlook: Where the Smart Capital Is Going in 2025

Continued demand for floating-rate notes (FRNs) as inflation hedges
Growth in infrastructure and essential services-backed bonds
Rising private investor flows into corporate and hybrid debt markets
SMSFs and family offices driving long-term allocations toward predictable yield strategies“

In today’s macro climate, fixed income isn’t a side allocation anymore – it’s the core of the modern portfolio,” McCallister adds.

About Quotient Capital
Quotient Capital Pty Ltd is a privately-owned wealth advisory firm based in Melbourne, Australia. Specialising in fixed income and private market strategies, the firm empowers sophisticated investors – including SMSFs, family offices, and high-net-worth individuals – with direct access to institutional-grade opportunities backed by deep research, transparency, and personalised advisory.

Office Address:
Collins Square Tower 5, 727 Collins Street, Melbourne VIC 3008
Phone: +61 3 9111 2441
Email: info@quotient-capital.com
Website: www.quotient-capital.com

Media Contact

For interviews, commentary, or speaker engagements on global fixed income, Australian credit markets, or private debt access:

Media Enquiries: pr@quotient-capital.com
Phone: +61 3 9111 2441

SOURCE: Quotient Capital Pty Ltd

Southeast Asian stem cell leader Medeze launches voluntary conditional cash partial offer for 10% stake in SGX-listed Cordlife Group Limited

Thailand-listed Medeze Group Public Company Limited (“Medeze”, together with its subsidiaries, the “Medeze Group”), through its wholly owned subsidiary Medeze Treasury Pte. Ltd. (the “Offeror”), intends to make a voluntary conditional cash partial offer (the “Partial Offer”) to acquire 10.00% of the issued ordinary shares of Cordlife Group Limited (“Cordlife” or the “Offeree”), a Singapore-listed provider of cord blood banking services. The move signals Medeze’s first strategic step into the Singapore market, with the intention of exploring business opportunities with the Offeree to create long-term value and mutual benefit for both parties.

Terms of the Partial Offer

Under the terms of the Partial Offer, the Offeror is seeking to acquire 25,630,774 shares, equivalent to 10.00% of Cordlife’s total issued and paid-up ordinary shares (excluding treasury shares) (the “Shares”), at an offer price of S$0.25 per share (the “Offer Price”). This represents an attractive premium of approximately 61.3% to the last traded price of S$0.155 on 9 May 2025, and also the 12-month volume-weighted average price.

The Partial Offer will be subject to the minimum acceptance condition of the Offeror having received, by the close of the Partial Offer, valid acceptances and/or tenders in respect of not less than 25,630,774 Shares, representing 10.00% of the total number of Shares (excluding treasury shares) as at the Record Date. The Partial Offer will not become or be capable of being declared unconditional in all respects unless the above condition is satisfied.

The Partial Offer represents an attractive opportunity for Cordlife shareholders to realise part or potentially all of their investment. Based on the Offeror’s observation that the Shares of the Offeree has been thinly traded in recent years, the Offer Price reflects a healthy premium over recent trading levels.

Rationale of the Partial Offer

The Partial Offer, if successful, will allow the Offeror to increase its direct holdings (including the existing shares held by the Offeror) in the Offeree to approximately 10.68% of the total number of Shares (excluding treasury shares) as at the Record Date. Upon successful completion of the Partial Offer, the Offeror, together with Medeze, will communicate with and endeavour to explore business opportunities with the Offeree to create long-term value and mutual benefit for both parties.

The Offeror wishes to demonstrate its commitment to contribute positively to the Offeree as a long-term substantial shareholder. By acquiring a meaningful stake, the Offeror aims to collaborate with existing controlling shareholders and management to drive sustainable value creation for all stakeholders. The Offeror believes in engaging in constructive dialogue and partnership with existing shareholders and management to align on strategic priorities, governance, and operational enhancements that will benefit the Offeree’s long-term success.

If a collaboration eventuates, Medeze Group and Cordlife could provide services to each other’s customers which helps to strengthen the market position and network of Medeze Group and Cordlife. As an example and for illustrative purposes only, Medeze Group could (where permissible), offer services like analyzing and storing NK cell and hair follicle banking services to Cordlife’s customers. Cordlife (where permissible) could on the other hand offer its chromosomal and genetic analysis and screening services to Medeze Group’s customers. This collaboration can further support the growth of both Medeze Group and Cordlife at the international level.

The Medeze Group recorded total revenue of THB 874.3 million and net profit of THB 338.7 million, representing growth of 23.6% and 41.4% year-on-year respectively. Medeze Group’s asset base more than tripled to over THB 3.4 billion, following its successful listing of the Stock Exchange of Thailand and strategic reinvestment into technology and capacity.

About Medeze

The Medeze Group has been in business for more than 14 years and is a leader in the Southeast Asia stem cell storage and services market.

Recognised as the Southeast Asia Stem Cell Banking Company of the Year by Frost & Sullivan for two consecutive years (2023 and 2024), the Medeze Group has a laboratory that is accredited by the Association for the Advancement of Blood and Biotherapies (AABB) from the United States. The laboratory is equipped with modern equipment and technology in the stem cell banking industry, such as AutoXpress and Quantum Machine.

The Medeze Group is founded and headed by the incumbent chief executive officer, Dr. Veerapol Khemarangsan, an experienced Obstetrics and Gynecology specialist, who brings deep clinical and commercial expertise. He continues to be personally involved in stem cell procedures, lending Medeze Group a rare combination of medical and operational leadership. He currently serves as the Director of Training Committee in Bangkok Metropolitan Endoscopic Center (BMEC).

For more information of the Medeze Group, please: https://www.medezegroup.com/th/.

About Cordlife

Cordlife was incorporated in Singapore on 2 May 2001 and has been listed on the Mainboard of the Singapore Exchange Securities Trading Limited (“SGX-ST”) since 29 March 2012. The Offeree is a group company in the business of providing cord blood banking services such as the collection, processing, testing, cryopreservation and storage of umbilical cord blood at birth in countries including Singapore, Hong Kong, Macau, Indonesia, Thailand, India and the Philippines.

For media queries, please contact:

Thailand
Investor Relations
Medeze Group
DID: +66 91 599 9999 (press 2)
Email: ir@medezegroup.com

Singapore
Tevinder Singh
Associate
Financial PR
DID: +65 6438 2990
Email: tevinder@financialpr.com.sg

The directors of the Offeror (including any director who may have delegated detailed supervision of the preparation of this document) have taken all reasonable care to ensure that the facts stated and opinions expressed in this document are fair and accurate and that no material facts have been omitted from this document, and they jointly and severally accept responsibility accordingly.

Where any information has been extracted or reproduced from published or otherwise publicly available sources or obtained from the Offeree, the sole responsibility of the directors of the Offeror has been to ensure through reasonable enquiries that such information is accurately extracted from such sources or, as the case may be, reflected or reproduced in this document.

OMP’s Unison Planning Achieves SAP(R) Certified Integration with RISE with SAP S/4HANA(R) Cloud

OMP, a global leader in supply chain planning solutions, announced today that its Unison PlanningTM platform has achieved SAP® certification as integrated with RISE with SAP S/4HANA® Cloud. Continuing its long history of providing SAP-certified integration, this milestone confirms Unison Planning’s full support for S/4HANA environments and its compatibility with RISE with SAP.

The integration delivers seamless, near-real-time connectivity between SAP and Unison Planning’s advanced supply chain capabilities, reinforcing OMP’s role as a trusted partner for navigating complex planning environments.

“Achieving this certification highlights our commitment to innovation and enterprise-grade reliability,” says Tom Wouters, Chief Product Officer at OMP. “It confirms our ability to support global businesses in their digital transformation journeys, especially those migrating to S/4HANA with RISE with SAP.”

OMP was recently recognized as a Leader in the Gartner® Magic Quadrant™ for Supply Chain Planning Solutions for the 10th consecutive time, positioned highest for Ability to Execute in 2025.

“We offer real solutions backed by real expertise,” adds Philip Vervloesem, Chief Commercial & Markets Officer at OMP. Many of our customers in various industries, including multiple Fortune 500 companies, are already reaping the benefits of using Unison Planning within their SAP S/4HANA environments. This certification helps companies migrating to SAP S/4HANA to integrate their non-SAP systems seamlessly with their SAP ERP, bringing peace of mind to both IT and business leaders.”

Key integration features of Unison Planning include:

Near-real-time extraction of master and transactional data relevant for demand, distribution, production planning, and sourcing.
Incremental synchronization of planning results,
No-code configurability of data selection and content.
Support for integration with multiple clients across mixed SAP landscapes (ECC, S/4HANA), especially valuable for businesses operating multiple SAP instances.

With the addition of this SAP-certified add-on, Unison Planning further simplifies deployment and strengthens interoperability in enterprise SAP environments.

The SAP Integration and Certification Center (SAP ICC) has certified that the integration software for Unison Planning integrates with RISE with SAP S/4HANA Cloud using standard integration technologies.

About OMP
OMP helps companies facing complex planning challenges excel, grow, and thrive by offering the best digitized supply chain planning solution on the market. Hundreds of customers in a wide range of industries – spanning consumer goods, life sciences, chemicals, metals, paper, plastics and packaging – benefit from using OMP’s unique Unison Planning™ platform.

Disclaimer
SAP and other SAP products and services mentioned herein, as well as their respective logos, are trademarks or registered trademarks of SAP SE in Germany and other countries. Please see https://www.sap.com/copyright for additional trademark information and notices. All other product and service names mentioned are the trademarks of their respective companies.

Contact Information
Philip Vervloesem
Chief Commercial & Markets Officer
pvervloesem@omp.com
+1-770-956-2723

SOURCE: OMP